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Abstract: Vascularization is a crucial factor when approaching any engineered tissue. Vascular
wall–mesenchymal stem cells are an excellent in vitro model to study vascular remodeling due to their
strong angiogenic attitude. This study aimed to demonstrate the angiogenic potential of experimental
highly porous scaffolds based on polylactic acid (PLA) or poly-e-caprolactone (PCL) doped with
calcium silicates (CaSi) and dicalcium phosphate dihydrate (DCPD), namely PLA-10CaSi-10DCPD
and PCL-10CaSi-10DCPD, designed for the regeneration of bone defects. Vascular wall–mesenchymal
stem cells (VW-MSCs) derived from pig thoracic aorta were seeded on the scaffolds and the expression
of angiogenic markers, i.e. CD90 (mesenchymal stem/stromal cell surface marker), pericyte genes
α-SMA (alpha smooth muscle actin), PDGFR-β (platelet-derived growth factor receptor-β), and NG2
(neuron-glial antigen 2) was evaluated. Pure PLA and pure PCL scaffolds and cell culture plastic
were used as controls (3D in vitro model vs. 2D in vitro model). The results clearly demonstrated
that the vascular wall mesenchymal cells colonized the scaffolds and were metabolically active. Cells,
grown in these 3D systems, showed the typical gene expression profile they have in control 2D
culture, although with some main quantitative differences. DNA staining and immunofluorescence
assay for alpha-tubulin confirmed a cellular presence on both scaffolds. However, VW-MSCs
cultured on PLA-10CaSi-10DCPD showed an individual cells growth, whilst on PCL-10CaSi-10DCPD
scaffolds VW-MSCs grew in spherical clusters. In conclusion, vascular wall mesenchymal stem cells
demonstrated the ability to colonize PLA and PCL scaffolds doped with CaSi-DCPD for new vessels
formation and a potential for tissue regeneration.
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1. Introduction
Vascularization is a crucial factor when approaching any engineered tissue [1]. A proper vascular
network should allow the transport of oxygen, nutrients and growth factors, as the diffusion limit to
maintain viable cells is only 400µm [2]. Moreover, vascular network should also act as a transport
system for hormones, waste products, toxic and non-functional substances [3], and should be a source of
growth factors locally produced by endothelial cells, such as pro-angiogenic morphogenetic factors [4].
In post-natal life, vascular remodeling is main due angiogenesis process. This process takes place
through cell recruitment and cell differentiation [4], with the involvement of growth factors such as
vascular endothelial growth factor (VEGF) and fibroblast growth factor-2 (FGF-2) [5].
Many tissue-specific stem cells/progenitors could be involved in neoangiogenesis [6], as vascular
stem cells and vascular wall-mesenchymal stem cells, residing in the wall of the large vessels, possess
excellent characteristics in inducing new vascularization [7–9] and are a promising resource in
regenerative medicine including tissue engineering.
A new method to isolate and culture vascular wall mesenchymal stem cells (VW-MSCs) from
the tunica media of pig thoracic aorta was previously described [10]. These cells have excellent
pro-angiogenic features either for their ability of differentiating in endothelial cells or capacity to
sustain a capillary network [11]. Moreover, the pro-angiogenic features of VW-MSCs secretome have
been demonstrated [12]. Overall, VW-MSCs are an excellent model for translational medicine for the
high similarity between human and pig.
Biodegradable synthetic polymers such as polylactic acid (PLA) and poly-e-caprolactone (PCL)
are currently used for scaffold design [13–15].
PLA is a green bioplastic produced through the bacteria fermentation of polysaccharide-based
natural resources (such as corn or starch), with the final result of lactic acid (monomer) and/or lactide
(dimer) polymerization [16]. PLA is used for different biomedical applications (including orthopedic
screws, fracture fixation devices and drug delivery applications) [13,15].
PCL is a biodegradable polyester, approved as implantable biomaterial by FDA and for different
applications in human body [14]. PCL is used in medicine for its properties of biocompatibility,
biodegradation and collagen stimulator [17].
Combination of biodegradable synthetic polymers with inorganic materials resulted in hybrid
biomaterials with suitable properties for tissue engineering [13,14].
Interestingly it has been reported that some ions have a significant role in neo-angiogenesis.
Silicon (Si) is an important element able to induce angiogenesis during new bone formation and to
accelerate bone regeneration [5,18].
Bioactive calcium silicate-based materials (CaSi) may provide interesting advantages in this
context in relationship to their chemistry as they expose silanol groups and release silicon [18–20].
CaSi demonstrated biointeractive properties [21,22], ion release (Ca and OH) [23] and the ability to
induce the differentiation of different populations of cells, such as orofacial bone mesenchymal stem
cells [24], cementoblasts [25], pulp cells [26], mesenchymal stem cells [27], and oral derived periapical
cyst mesenchymal stem cells [28].
The inclusion of calcium phosphates, such as dicalcium phosphate dihydrate (DCPD) into CaSi
materials demonstrated to enhance their biological properties and apatite-forming ability [21,22,24].
Moreover, when CaSi are used as filler in a polymeric matrix, such as PLA or PCL, the high
alkalizing ability may counterbalance the acidic degradation products of synthetic poly-α-hydroxyl
polymers [29,30]. These properties support their role as filler in tissue engineering. Some scaffolds
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have been designed for angiogenic and osteogenic purposes containing bioactive calcium silicates [31].
Recently, highly porous PLA and PCL scaffolds doped with bioactive calcium silicates and calcium
phosphates have been designed [28–30]. Mineral-doped PLA scaffolds demonstrated the ability to
be colonized by oral derived mesenchymal stem cells and to stimulate their shift through osteogenic
lineage [28]. Highly porous mineral-doped PCL scaffolds showed interesting biointeractive properties
and the ability to nucleate apatite, enhancing the biological properties of pure PCL [30].
The aim of the present study was to evaluate the ability of VW-MSCs to colonize experimental
highly porous based mineral-doped poly-α-hydroxyl scaffolds, and to express their angiogenic potential.
PLA- and PCL-based scaffolds doped with CaSi and DCPD have been used as 3D model and tested for
the gene expression of angiogenic markers CD 90, α-SMA, PDGFR-β and NG2 of VW-MSCs. Pure
PLA and PCL scaffolds and cell plastic were used as control (3D in vitro model vs. 2D in vitro model).
2. Materials and Methods
2.1. Scaffolds Preparation
PLA (IngeoTM biopolymer PLA 4060D, Natureworks LLC, Blair, NE, USA) having average
Mw = 65,000 g/mol was received in pellet form. PCL (Sigma-Aldrich, Milan, Italy) having average
Mw = 45,000 g/mol was received in pellet form.
Prior their use, the synthetic polymers were purified by means of dissolution in 10% wt/vol
(for PLA) or 15% wt/vol (for PCL) of CHCl3 solutions (HPLC grade, Sigma-Aldrich, Milan, Italy),
followed by reprecipitation in pre-cooled methanol (Sigma-Aldrich, Milan, Italy) to eliminate residual
polymerization catalysts.
CaSi, composed of dicalcium and tricalcium silicates, tricalcium aluminate and calcium sulfate
(Aalborg, Denmark) and DCPD (CaHPO4·2H2O, Sigma-Aldrich, Steinheim, Germany) powders were
obtained by melt-quenching technique and milling procedures [26] and used as mineral fillers.
The scaffolds were prepared through TIPS according to a previous protocol [28–30]. PLA or PCL
solutions in 1,4-dioxane were obtained, reaching a 3.5% wt/vol concentration. CaSi and DCPD mineral
powders were added in 10% by weight with respect to PCL or PLA. The solutions were sonicated
for 3 h using a ultrasonic processor UP50H (Hielsher, Teltow, Germany; operative parameters 50 W,
30 kHz) with a 2 mm sonotrode MSD titanium tip, then put inside 60 mm plates and cooled at −18 ◦C
for 18 h. Finally, the frozen samples were extracted and immersed in an ethanol bath (Sigma-Aldrich,
Milan, Italy) precooled at −18 ◦C for 18 h, with a solvent refresh every 3 h [29,30].
For each formulation, 6 disks (diameter 60 ± 1 mm, thickness 10 ± 0.1 mm) were prepared, namely
PLA, PLA-10CaSi-10DCPD, PCL, and PCL-10CaSi-10DCPD.
2.2. Surface Porosity Evaluated by the Morphometric Analysis on ESEM Images
The scaffolds were cut into samples (10.00 ± 1.00 mm height, 15.00 ± 1.00 mm length and
10.00 ± 1.00 mm width; n = 3 per formulation) and examined using an environmental scanning electron
microscope (ESEM, Zeiss EVO 50; Carl Zeiss, Oberkochen, Germany). The samples were placed
directly onto the ESEM stub without any preparation (uncoated) and investigated in wet conditions
at low vacuum (100 Pa) in Quadrant Back-Scattering Detector (QBSD) (operative parameters: 20 kV
accelerating voltage, 8.5 mm working distance, 0.5 wt% detection level, 133 eV resolution, 100 µs
amplification time and 60 s measuring time).
The images were analyzed using Image J program (National Institutes of Health, Bethesda, MY,
USA) to evaluate the surface porosity of the scaffolds, calculated as the ratio between the blackest areas
(corresponding to the micropores) and the total investigated area [29,32].
Measurements were made in triplicate on three different areas at both 500× and 1000×
magnification, and the mean value for each magnification was recorded.
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2.3. Isolation and Culture of Primary Porcine Vascular Wall Mesenchymal Stem Cells
Three-month old female pigs (Large White) were euthanized for different experimental
investigation and primary VW-MSCs were isolated from the thoracic aorta in order to generate
three primary cell culture replicates following a previously described methodology [11,33].
All procedures on animals were reviewed and approved in advance by the Ethical Committee
of the University of Bologna (Bologna, Italy) and then approved by the Italian Ministry of Health
(Protocol number n.43-IX/9 all.37; 20/11/2012).
Plastics used for standard culture condition were from BD-Falcon (Corning, NY, USA). DAPI
solution for DNA staining and antibiotic–antimycotic Dulbecco’s phosphate buffered saline (DPBS,
Gibco-Life Technologies, Carlsbad, CA, USA).
Trypsin–EDTA solution 1X was purchased from Sigma-Aldrich (St. Louis, MO, USA). Growth
medium (Promocell Pericyte Growth Medium) (PGM, Promocell GmbH, Heidelberg, Germany).
All the experiments were performed with cells at passage 3 and cultured in PGM
(Heidelberg, Germany).
2.4. Cell Seeding Efficiency Assay
All the scaffolds were sterilized by 30 min of incubation in absolute EtOH followed by three
washes in DPBS (30 min each one). Then cubic-shaped sections of about 1 mm on each side were
produced using scalpel blades 30 sections were inserted into a microtube containing 500 µL of PGM
culture medium and incubated over night at 4 ◦C. The day after, VW-MSCs were seeded on different
biomaterials (PLA-10CaSi-10DCPD and PCL-10CaSi-10DCPD) following a published method [34] with
some main adaptations. Microtubes with the biomaterials were incubated to reach a temperature of 38
◦C. The medium was then separated, and biomaterials were drop-seeded with 100 µL of a concentrated
cell suspension containing 4 × 105 or 8 × 105 cells.
The microcentrifuge tubes were placed on a rocker oscillating at 30 rpm for 2 h to permit initial
cell attachment then 1 mL of fresh cell culture medium was slowly added to each tube and cells were
cultured for additional 24, 48, 72 h in static condition at 38.5 ◦C at 5% CO2. Cell-free biomaterials were
incubated under same conditions and used as control.
Cell seeding efficiency (CSE) was estimated using an indirect method [34] after 24, 48 and 72 h.
Briefly, CSE was calculated using the following equation: CSE (%) = (1 − cellsu/cellsi) × 100, where
cellsi is the number of cells initially seeded and cellsu is the number of unattached cells in the residual
medium and in DPBS used for rinsing cell-seeded biomaterials. Unattached cells were counted by
hemocytometer in three different aliquots of medium collected from each sample.
2.5. Metabolic Cell Activity Assay
The metabolic activity of VW-MSCs was monitored at 24, 48 and 72 h using MTT based assay
(Sigma-Aldrich, MO, USA), following the manufacturer’s instruction, with some main adaptation.
After the removal of the medium, scaffolds were washed two times with DPBS. Then, 20 µL of MTT
substrate was added and recovered for 4 h at 38.5 ◦C at 5% CO2. After that, 200 µL of solubilisation
solution was added and, after 30 min, the solution was vigorously mixed. Finally, the absorbance
was measured spectrophotometrically at a wavelength of 570 nm, with the background subtraction at
690 nm.
2.6. RNA Extraction and qPCR
TRI Reagent (Molecular Research Center, Inc, Cincinnati, OH, USA) and NucleoSpin RNA II kit
(Macherey-Nagel GmbH & Co. KG, Düren, Germany) were purchased and used for RNA extraction.
Briefly, culture medium was removed after 72 h and different scaffolds where washed twice with
DPBS; 500 mL of TRI Reagent (Molecular Research Center, Inc.) was supplemented and the materials
were lysed using a TH Tissue Homogenizer (Omni International, GA, USA).
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Subsequently, 100 µL of chloroform was added to the solution, mixed and incubated at room
temperature for 10 min. Samples were then centrifuged at 12,000× g for 10 min to recover the
aqueous phase.
Absolute ethanol (99%) was added in equal volume to the solution and then submitted to the
Nucleo spin RNA Column. RNA was finally purified according to the manufacturer’s instructions.
Total RNA (500 ng) was quantified spectrophotometrically (Denovix, Denovix Inc., Wilmington,
NC, USA) and then reverse-transcripted to cDNA using the iScript cDNA Synthesis Kit (Bio-Rad
Laboratories Inc., Hercules, CA, USA) in a final volume of 20 µL.
Selection of swine primers was performed using Beacon Designer 2.07 (Premier Biosoft
International, Palo Alto, CA, USA).
Quantitative real-time PCR (qPCR) was carried out to analyze gene expression profile in CFX96
thermal cycler (Bio-Rad, Hercules, CA, USA), using a multiplex real time reaction for reference
genes (namely glyceraldehyde-3-phosphate dehydrogenase, hypoxanthine guanine phosphoribosyl
transferase andβ-Actin). Taq-Man probes and SYBR green detection were used for the expression of the
following target pericyte genes: CD90 (mesenchymal stem/stromal cell surface marker), α-SMA (alpha
smooth muscle actin), PDGFR-β (platelet-derived growth factor receptor-β), and NG2 (neuron-glial
antigen 2).
All amplification reactions were performed in 20 µL and analyzed in duplicates (10 µL/well).
Multiplex PCR contained: 10 µL of iTaqMan Probes Supermix (Bio-RAD), 1 µL of forward and reverse
primers (5 µM each) of each reference gene, 0.8 µL of iTaq-Man Probes (5 µM) of each reference gene,
2 µL cDNA and 2.6 µL of water. The following temperature profile was used: initial denaturation at
95 ◦C for 30 s followed by 40 cycles of 95 ◦C for 5 s and 60 ◦C for 30 s.
The SYBR Green reaction contained: 10 µL of IQSYBR Green Supermix (Bio-RAD), 0.8 µL of
forward and reverse primers (5 µM each) of each target gene, 2 µL cDNA and 7.2 µL of water. The
real-time program included an initial denaturation period of 1.5 min at 95 ◦C, 40 cycles at 95 ◦C for 15 s,
and 60 ◦C for 30 s, followed by a melting step with ramping from 55 ◦C to 95 ◦C at a rate of 0.5 ◦C/10 s.
The specificity of the amplified PCR products was confirmed by agarose gel electrophoresis and
melting curve analysis.
Gene relative expression was normalized according to the geometric mean of the reference genes.
mRNA relative expression was analysed as fold increase using the 2−∆∆CT method [35], control group
was constituted by VW-MSCs cultured in flask under standard 2d culture condition.
2.7. DAPI Staining and Immunofluorescence
To test the cellular distribution on the different scaffolds, VW-MSCs cultured for 72 h were
processed for labelling DNA in fluorescence with DAPI staining and alpha-tubulin immunofluorescence.
Biomaterials were washed twice in DPBS then were fixed overnight in cold 4% formaldehyde solution
in PBS, pH 7.4. Each sample was transferred into a 25% sucrose (Sigma-Aldrich, MO, USA) solution in
PBS at 4 ◦C for 24 h to get cryoprotection. Finally, samples were embedded and freezed in OCT (Sakura
Finetek, CA, USA). Ten micrometres sections were cut at a Leica CM1950 cryostat (Leica, Wetzlar,
Germany) mounted on microscope’s slides and stained with DAPI Staining Solution (Thermo Fischer
Scientific, Rockford, IL, USA). For immunofluorescence staining slides were completely dried at room
temperature, washed three times in PBS 1X for 5 min, permeabilized with Triton X-100 0.1% in PBS 1X
for 1 h then washed three times in PBS 1X for 5 min. For aspecific sites blocking slides were treated with
10% Normal Goat Serum in PBS 1X for 1 h at RT then incubated overnight in a humidified chamber
with an anti-alpha-tubulin antibody (Clone TU-01, Thermo Fisher Scientific, Waltham, MA, USA)
diluted 1:250 in PBS 1X. In negative controls, the primary antibody was omitted. Then samples were
washed three times in PBS 1X, incubated with anti-mouse FITC conjugate antibody (Sigma-Aldrich, St.
Louis, MO, USA) diluted 1:100 in PBS 1X for 1 h at RT in a humidified chamber. After two washes for
5 min in PBS 1X and one wash in distilled water for 5 min, coverslips were mounted on slides with
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Fluoreshield with PI (Sigma-Aldrich, St. Louis, MO, USA). Photomicrographs were obtained using a
Nikon digital camera installed on a Nikon (Nikon Inc., Melville, NY, USA).
2.8. Statistical Analysis
Three primary cell cultures derived from three different animals were used. Data represent the
mean ± SD (or ± range of expression for qRT-PCR) of the three biological replicates. Data analysis was
carried out with Prism 5.0 software (GraphPad Software Inc., San Diego, CA, USA). One-way analysis
of variance (ANOVA) followed by Tukey post hoc comparison Test was used. p values < 0.05 were
considered statistically significant.
3. Results
3.1. Surface Porosity Evaluated by the Morphometric Analysis on ESEM Images
The mean value of surface porosity valuated at 500× and 1000× was 45.49% and 51.08 for PLA
scaffolds (Figure 1a) and 31.51% and 26.94% for PLA-10CaSi-10DCPD scaffolds (Figure 1b).
Figure 1. Surface porosity evaluation of PLA (a) and PLA-10CaSi-10DCPD (b) scaffolds on one random
area at 500× and 1000× magnifications. Mineral doped formulation revealed a more compact surface,
with a lower number of porosities when compared to pure PLA formulation.
Nanomaterials 2020, 10, 243 7 of 14
Surface porosity of PCL scaffolds estimated at 500× and 1000× magnifications was slightly higher
when compared to PLA, namely 51.58% and 52.22%, respectively (Figure 2a).
Similarly, the porosity of scaffolds PCL-10CaSi-10DCPD was 41.42% and 41.65%, respectively
(Figure 2b).
Figure 2. Surface porosity evaluation of PCL (a) and PCL-10CaSi-10DCPD (b) scaffolds on one random
area at 500× and 1000× magnifications. PCL scaffolds reveal a more regular surface with larger
porosities when compared to PLA scaffolds. CaSi and DCPD mineral fillers are widely distributed on
the scaffold surface, partially occluding the pores.
3.2. Cytocompatibility
To investigate the VW-MSCs ability to colonize biomaterials, cell seeding efficiency (CSE) was
quantified (Figure 3). Results indicated a significant efficiency rate at 24 h, both for PLA and PCL
matrix (≥90%), and the presence of additives did not influence the cell seeding efficiency.
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Figure 3. Cell seeding efficiency performed through an indirect method. After 24 h from the seeding
on the scaffold surface, the unattached cells were quantified and cell seeding efficiency was calculated
by the equation: CSE (%) = (1 − cellsu/cellsi) × 100. Data represent the mean ± SD of three independent
biological replicates (n = 3) and were analysed using one-way ANOVA followed by the Tukey’s post
hoc comparison. No differences were detected among different scaffolds.
3.3. Metabolic Activity
In order to measure the metabolic activity of VW-MSCs grew on the scaffolds, a MTT based assay
method was performed on cells 24, 48, and 72 h post seeding. The results showed that VW-MSCs
maintain a metabolically active state when seeded on all the materials. After 48 h cells seeded on
PLA and PLA-10CaSi-10DCPD showed higher metabolic activity compared to cells seeded on PCL or
PCL-10CaSi-10DCPD (Figure 4).
Figure 4. Metabolic activity of VW-MSCs seeded on the different scaffolds after 24, 48 and 72 h of culture
was evaluated by MTT based assay. The data represented as the mean ± SD of three independent
biological replicates (n = 3), were analysed using one-way ANOVA followed by the Tukey’s post hoc
comparison. Significant differences among the experimental scaffolds are represented by asterisks (*)
(p < 0.05).
3.4. Effect of Biomaterials on VW-MSCs Markers
VW-MSCs cultured in PGM on the surface of different scaffolds expressed all the studied genes
(Figure 5). Interestingly, qPCR analysis revealed a statistically significant downregulation of α-SMA
in VW-MSCs cultured on PCL scaffolds, in relation to the VW-MSCs cultured under standard 2D
condition (CTR) (Figure 5). The presence of CaSi and DCPD additives restored the basal level.
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Figure 5. Expression of CD90, αSMA, NG2, and PDGFR-β genes in VW-MSCs evaluated after 72 h of
culture in the presence of different experimental 3D scaffolds or in 2D standard culture condition (CTR).
Data represent mean ± range of relative expression (RE) of three biological replicates (n = 3). Data
were analysed using one-way ANOVA followed by the Tukey’s post hoc comparison test. Statistically
significant differences among the scaffolds are represented by asterisks (*) (p < 0.05).
On the contrary, PDGFR-β always decreased in both PLA and PCL scaffolds in the presence of
CaSi and DCPD.
3.5. VW-MSCs Distribution on Different Scaffolds
DAPI staining and immunofluorescence assay for alpha-tubulin confirmed cellular presence
on all the experimental 3D scaffolds. Interestingly, a difference in cellular distribution was
observed. On PLA-10CaSi-10DCPD scaffolds VW-MSCs grew individually (Figure 6c,e), whilst on
PCL-10CaSi-DCPD scaffolds, VW-MSCs grew in spherical cluster (Figure 6d,e). The same distribution
was also observed also for VW-MSCs cultured on the non-doped scaffolds (data not shown).
Figure 6. DAPI staining for PLA-10CaSi-10DCPD (a) and PCL-10CaSi-10DCPD (b) without cells
and in the presence of 72 h cultured cells: PLA-10CaSi-10DCPD (c), PCL-10CaSi-10DCPD (d).
Immunofluorescence analysis for alpha-tubulin of 72 h cultured cells on PLA-10CaSi-10DCPD (e) and
PCL-10CaSi-10DCPD (f). Scale bar = 50 µm for a–d and 20 µm for e,f, *indicate spherical cluster.
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4. Discussion
Mineral doped scaffolds, composed of a biodegradable synthetic polymer and bioactive mineral
fillers showed attractive properties for their use in bone tissue engineering [13,30]. Biodegradable
synthetic polymers such as those based on poly-α-hydroxyl acids (as PLA and PCL) are currently used
for scaffold design, as they are biocompatible, biodegradable, with an appropriate shelf-life, may be
produced with a low cost process and may be adapted to the surgical site [13,15].
Highly porous poly-lactic acid scaffolds doped with bioactive calcium silicates and calcium
phosphates have been recently designed [28,29] and demonstrated the ability to be colonized by oral
derived mesenchymal stem cells and to stimulate their shift through osteogenic lineage [27,36]. Calcium
silicates/poly-e-caprolactone 3D printed scaffolds designed for dental pulp tissues revascularization
purposes showed good dental pulp stem cell proliferation and osteogenic differentiation [37].
As vascularization is a crucial factor when approaching any engineered tissue, new scaffolds,
able to promote local angiogenesis, could represent a multi-approach strategy to obtain the best result
in engineered tissue.
Designed scaffolds showed a uniform surface porosity. Both PCL scaffolds formulations (pure
PCL and mineral doped polymer) revealed higher surface porosity of scaffolds than PLA formulation.
These values were in line with two recently published papers [29,30].
Recent studies demonstrated that PLA and PCL formulations doped with CaSi were able to leach
biologically relevant ions (Ca and OH) and to nucleate apatite on its surface [29,30]. Both ions are
biologically relevant for new bone tissue formation, as Ca ions act as a powerful signal for mineralizing
cells [38] and the alkaline environment demonstrated to increase apatite nucleation [27]. Moreover, Si is
an important element for angiogenesis induction during the early phases of bone regeneration and new
bone tissue formation [5,19]. Indeed, Si may be localized in young bone active calcification sites [39].
Si from CaSi (such as bioglasses, ackermanite, wollanstonite) is able to increase gene expression of VEGF
and FGF, two important pro-angiogenic cytokines [20,37] and upregulate the downstream signalling
of nitric oxide synthesis, genes and activity [19,40,41]. Several CaSi (ackermanite and wollanstonite)
were able to trigger the secretion of angiogenic growth factors from fibroblasts, with the result of a
higher number of blood vessel infiltration intro tissue-engineered scaffolds [41].
In the present study, VW-MSCs have been cultured on experimental 3D porous scaffolds based on
PLA and PCL doped with high amounts (20% w/w) of reactive biointeractive mineral fillers (CaSi and
DCPD). The used vascular stem cells derived from the thoracic aorta [10] represent an excellent model
to test the angiogenic/anti angiogenic potential of different substances/materials [42].
The results of this paper clearly demonstrate that both experimental PLA- and PCL-based mineral
doped scaffolds support VW-MSCs growth and colonization; VW-MSCs grown on all the scaffolds
were metabolically active throughout the experimental time (72 h). Interestingly, at 48 h, VW-MSCs
cultured on PLA-based scaffold showed an increase of metabolic activity respect to PCL-based scaffold
regardless of the presence of the doping agents. The difference in metabolic profile found for PLA
based scaffolds must be further investigated, considering that a different metabolic activity could
represent a stem cells differentiation fate towards different specific lineages [43].
We previously demonstrated [11] that VW-MSCs cultured in 2D are characterized by a typical
gene expression profile including mesenchymal stem cell markers, such as CD90 and pericyte
markers such as alpha smooth muscle actin (α-SMA) [44], platelet-derived growth factor receptor-β
(PDGFR-β) [45,46] and neuron-glial antigen 2 (NG2) [46]. Similarly, VW-MSCs cultured on both the
experimental 3D scaffolds express these angiogenesis markers suggesting the possibility of a successful
long-lasting colonization.
In the present study the cells isolated from the media of thoracic aorta and grown on the scaffolds
showed CD90+. CD90 is expressed by the stromal lineage cells as pericytes and resident adventitial
adult human mesenchymal stem cells [47]. In fact, the vascular wall is a source of multipotent and
lineage-restricted progenitor cells, which are isolated from all the layers of large vessel, including
Nanomaterials 2020, 10, 243 11 of 14
aorta [9]. The functional capabilities of various stromal vascular fraction constituents during the
process of neovascularization have been reported [48].
PLA and PCL scaffolds doped with CaSi and DCPD mineral fillers showed the expression of
alpha-SMA whilst PCL scaffold (control) caused a reduction of alpha-SMA expression. The expression
of α-SMA—the actin isoform typical of vascular smooth muscle cells [44]—indicates the angiogenic
differentiation on the experimental scaffolds.
In contrast, PDGFR-β was significantly reduced in scaffolds enriched with reactive minerals
CaSi and DCPD, mainly in the PCL mineral doped scaffold. On the contrary, PLA increased the
PDGFR-β expression.
PDGFR-β is a particularly critical factor that regulates the recruitment and proliferation of vascular
cells [45] and regulates angiogenesis by inducing the transcription and secretion of VEGF. PDGF
is released mainly by endothelial cells and binds to the PDGFR-b on perivascular cells. PDGFR-β
activation stimulates the proliferation of perivascular cells, resulting a powerful chemoattractant
inducing cells to migrate and expanding the endothelial cell populations [49]. PDGF-β/PDGFR-β
receptor role in angiogenesis has been well-described and correlated with the increase of vascularity
and the vascular wall maturation. PDGFR- β is expressed by vascular smooth muscle cells and
pericytes and plays an important role in these cells proliferation during vascular growth [50]. PDGFR-β
expression from pericytes is necessary for their recruitment and integration in the vascular wall [51],
the increase of the expression of this receptor is accompanied by enhanced vascular development,
followed by angiogenic sprouting with abundant pericyte coating and increased expression of VEGF
and receptor activation in endothelial cells [52].
The results of this study are particularly attractive, and further investigation, increasing the time
of culturing could explain if the different levels of α-SMA and PDGFR-β expression could be associated
with different spontaneous differentiation. Interestingly, the expression of NG2, early marker of
pericytes [53–55], is significantly higher in all the scaffolds than in the plastic control indicating a
stimulatory effect of the scaffolds towards an early stage vascularization.
Pericytes form an outer sheet around the endothelium and may contribute to the creation of
microvessels on the surface and into the deep portion of scaffold after their placement in body sites,
such as maxilla bone defect or peri implant and root bone pockets.
The distribution of VW-MSCs cultured on the experimental 3D scaffolds showed an individual cell
growth on PLA-10CaSi-10DCPD whilst on PCL-10CaSi-10DCPD cells grown as compact clusters, which
resemble the spheroids that could be obtained by hanging drop culture of VW-MSC. The difference
in gene expression could be related to this different cell distribution. It is well known that MSCs
phenotype is dramatically changed when culture condition shifts from 2D to 3D and also depends
on the modality of the cell colonization and aggregation (development of multi-cellular aggregates,
commonly known as spheroids) on the surface; while the difference in α-SMA and PDGR-β expression
seems to be related to the presence of mineral additives.
Overall, we demonstrated the possibility of culturing VW-MSCs on 3D biodegradable highly
porous mineral doped poly-α-hydroxy acids scaffolds. VW-MSCs spontaneously colonize these
biomaterials and maintain a general undifferentiated phenotype in the first 72 h of culture with slight
differences with control 2D culture. The experimental 3D scaffolds allow the expression of angiogenic
markers by VW-MSCs after 72 h of culture. Further studies, with longer growth kinetics, are needed
to investigate the differentiated fate of these cells grown on the experimental 3D culture systems
containing CaSi and calcium phosphate for pulp and bone regeneration [56].
Being VW-MSCs an excellent in vitro model to study vascular remodeling, due to their strong
angiogenic attitude, and the possibility of culturing VW-MSCs on these biodegradable scaffolds
represents a strategy for biomedical tissue engineering.
In conclusion, the property of the experimental materials to be colonized by vascular stem cells
and to allow the expression of angiogenic markers demonstrated the potential of the scaffolds to
allow/induce the formation of new microvessels. The study supports their potential application in
Nanomaterials 2020, 10, 243 12 of 14
tissue regeneration as in oral bone defects and in pulp tissue regeneration, both conditions which
require the fast formation of a new 3D vascular network.
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